Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02143401
Title Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic in Arizona Scottsdale Arizona 85259 United States Details
University of California Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
UCHealth University of Colorado Hospital Aurora Colorado 80045 United States Details
Mayo Clinic in Florida Jacksonville Florida 32224-9980 United States Details
University of Iowa/Holden Comprehensive Cancer Center Iowa City Iowa 52242 United States Details
University of Maryland/Greenebaum Cancer Center Baltimore Maryland 21201 United States Details
Mayo Clinic in Rochester Rochester Minnesota 55905 United States Details
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York New York 10032 United States Details
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 United States Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field